Peer-reviewed journal articles (187)
  1. 1. Ando, K., Htut Thazin, M., Antonelli, E. M., Kosa, A.-C., López Gutiérrez, L., Quintanilla Sanchez, C., Aydin, E., Doeraene, E., Nagaraj, S., Ramos, A. R., Coulonval, K., Roger, P. P., Brion, J. P., & Leroy, K. (2025). Dysregulation of Inositol Polyphosphate 5-Phosphatase OCRL in Alzheimer’s Disease: Implications for Autophagy Dysfunction. International journal of molecular sciences, 26(12), 5827.
  2. 2. Ando, K., Kosa, A.-C., Mehadji, Y., Lasri, H., López Gutiérrez, L., Quintanilla Sanchez, C., Aydin, E., Doeraene, E., Wathelet-Depauw, A., Nagaraj, S., Brion, J. P., & Leroy, K. (2025). Deletion of Murine APP Aggravates Tau and Amyloid Pathologies in the 5xFADXTg30 Alzheimer’s Disease Model. Biomolecules, 15(2), doi.org/10.3390/biom15020159, 159.
  3. 3. Nagaraj, S., Quintanilla Sanchez, C., Ando, K., López Gutiérrez, L., Doeraene, E., Kosa, A.-C., Aydin, E., Brion, J. P., & Leroy, K. (2024). Downregulation of hsa-miR-132 and has-miR129: non-coding RNA molecular signatures of Alzheimer's disease. Frontiers in Molecular Neuroscience, 17(2), 10.3389/fnmol.2024.1423340.
  4. 4. Ando, K., Küçükali, F., Doeraene, E., Nagaraj, S., Antonelli, E. M., Htut Thazin, M., Yilmaz, Z., Kosa, A.-C., López Gutiérrez, L., Quintanilla Sanchez, C., Aydin, E., Ramos, A. R., Mansour, S., Turbant, S., Schurmans, S., Sleegers, K., Erneux, C., Brion, J. P., & Leroy, K. (2024). Alteration of gene expression and protein solubility of the PI5- phosphatase SHIP2 are correlated with Alzheimer's disease pathology progression. Acta Neuropathologica, 147(94), 10.1007/s00401-024-02745-7.
  5. 5. Basheer, N., Buée, L., Brion, J. P., Smolek, T., Muhammadi, M. K., Hritz, J., Hromadka, T., Dewachter, I., Wegmann, S., Landrieu, I., Novak, P., Mudher, A., & Zilka, N. (2024). Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models. Acta neuropathologica communications, 12(1), 52. doi:10.1186/s40478-024-01748-5
  6. 6. Gilloteaux, J., De Swert, K., Suain, V., Brion, J. P., & Nicaise, C. (2023). Loss of Ephaptic Contacts in the Murine Thalamus during Osmotic Demyelination Syndrome. Ultrastructural pathology, 47(5), 398-423. doi:10.1080/01913123.2023.2232452
  7. 7. Ando, K., Nagaraj, S., Küçükali, F., De Fisenne, M.-A., Kosa, A.-C., Doeraene, E., López Gutiérrez, L., Brion, J. P., & Leroy, K. (2022). PICALM and Alzheimer’s Disease: An Update and Perspectives. Cells, 11(24), 3994. doi:10.3390/cells11243994
  8. 8. De Fisenne, M.-A., Yilmaz, Z., De Decker, R., Suain, V., Buée, L., Ando, K., Brion, J. P., & Leroy, K. (2022). Alzheimer PHF-tau aggregates do not spread tau pathology to the brain via the Retino-tectal projection after intraocular injection in male mouse models. Neurobiology of disease, 174, 105875. doi:10.1016/j.nbd.2022.105875
  9. 9. Sáez-Orellana, F., Leroy, T., Ribeiro, F., Kreisler, A., Leroy, K., Lalloyer, F., Baugé, E., Staels, B., Duyckaerts, C., Brion, J. P., Gailly, P., Octave, J. N., & Pierrot, N. (2021). Regulation of PPARα by APP in Alzheimer disease affects the pharmacological modulation of synaptic activity. JCI insight, 6(16). doi:10.1172/jci.insight.150099
  10. 10. Sexton, C., Snyder, H., Beher, D., Boxer, A. A., Brannelly, P., Brion, J. P., Buée, L., Cacace, A. A., Chételat, G., Citron, M., DeVos, S. L., Diaz, K., Feldman, H. H., Frost, B., Goate, A. A., Gold, M., Hyman, B., Johnson, M. K., Karch, C. M., Kerwin, D. D., Koroshetz, W. W., Litvan, I., Morris, H. R., Mummery, C. C., Mutamba, J., Patterson, M. M., Quiroz, Y. Y., Rabinovici, G. D., Rommel, A., Shulman, M. M., Toledo-Sherman, L. L., Weninger, S., Wildsmith, K. K., Worley, S. S., & Carrillo, M. M. (2021). Current directions in tau research: Highlights from Tau 2020. Alzheimer's & Dementia, 18, 988-1007. doi:10.1002/alz.12452
  11. 11. Gilloteaux, J., Bouchat, J., Bielarz, V., Brion, J. P., & Nicaise, C. (2021). A primary cilium in oligodendrocytes: a fine structure signal of repairs in thalamic Osmotic Demyelination Syndrome (ODS). Ultrastructural pathology, 45(2), 128-157. doi:10.1080/01913123.2021.1891161
  12. 12. Ando, K., Erneux, C., Homa, M., Houben, S., De Fisenne, M.-A., Brion, J. P., & Leroy, K. (2021). Dysregulation of Phosphoinositide 5-Phosphatases and Phosphoinositides in Alzheimer's Disease. Frontiers in Neuroscience, 15, 614855. doi:10.3389/fnins.2021.614855
    13. << Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Next >>